Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
GILD AMGN BIIB CELG Hybrid Mix Commodities Exotic Emerging Markets 
United States  USA  |  Investing Toolset


Processing
Processing. Please wait...

BioTime Cash per Share

 
 Companies |  Insiders  | Dashboard  
     

Cash per Share breakdown for BioTime

Cash per Share is a ratio of current cash on hands or in the banks of the company to total number of shares outstanding. It is used to determine firm's liquidity and is a good indicator of overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

BioTime

Cash per Share

=

Total Cash

Average Shares

=
0.19 times
Companies with high Cash per Share ratio will be considered as attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals
Compare BioTime to competition

BioTime Cash per Share Assessment

In accordance with recently published financial statements BioTime Inc has Cash per Share of 0.19 times. This is 95.96% lower than that of Healthcare sector, and 92.69% lower than that of Biotechnology industry, The Cash per Share for all stocks is 95.71% higher than the company.

Filter other Stocks by Cash per Share

Select Cash per Share Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  

Cash per Share Comparison

BioTime is currently under evaluation in cash per share category among related companies.
Follow BioTime Cash per Share with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add BioTime to your reader
 
    
BTX United States AMEX
BioTime Inc
Currency: USD - US Dollar
Traded on American Stock Exchange
    
    

Other BioTime Fundamentals

Return On Equity(83.51) %
Return On Asset(46.22) %
Operating Margin(708) %
Current Valuation204.52 M
Shares Outstanding49.38 M
Shares Owned by Insiders47.78 %
Shares Owned by Institutions13.00 %
Number of Shares Shorted6.84 M
Price to Book19.95 times
Price to Sales48.81 times
Revenue3.88 M
Gross Profit3.48 M
EBITDA(24.55 M)
Net Income(24.17 M)
Cash and Equivalents9.9 M
Cash per Share0.19 times
Current Ratio3.02 times
Book Value Per Share0.19 times
Cash Flow from Operations(19.68 M)
Short Ratio47.20 times
One Year High5.07
One Year Low2.67
Earnings Per Share(0.49) times
Number of Employees73
Beta1.06
Market Capitalization201.48 M
Total Asset29.75 M
Retained Earnings(101.9 M)
Working Capital2.79 M
Current Asset7.18 M
Current Liabilities4.39 M
Z Score-4.2
Probability Of Bankruptcy88.20 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium